Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 please find enclosed the details of the meeting to be held with Analyst/institutional investor.

Syngene International Limited provides contract research and manufacturing services to the pharmaceutical industry. The Company offers chemical and formulation development, polymer research, large molecule and clinical development, and stability services. Syngene International serves customers worldwide.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our letter dated September 14, 2023, we hereby inform you that the meeting scheduled with Putnam Investment Management, on September 21, 2023, has been postponed and the details of the rescheduled meeting to be held on September 25, 2023.

Amendment to the Syngene Employee Welfare Trust Deed

Amendment To The Syngene Employee Welfare Trust Deed.

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 please find enclosed the details of the rescheduled meeting to be held with Analyst/institutional investor.

52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00